EU finds J&J COVID shot possibly linked to another rare clotting condition

The European Union's drug regulator said on Friday there is a possible link between rare cases of bloods clots in deep veins with Johnson & Johnson's COVID-19 vaccine and recommended the condition be listed as a side-effect of the shot. The European Medicines Agency also recommended immune thrombocytopenia (ITP), a bleeding disorder caused by the body mistakenly attacking platelets, be added as an adverse reaction with an unknown frequency to the J&J vaccine product information and to AstraZeneca's vaccine.